In a new job - September 7, 2020
Nanoform expands its global commercial team
Nanoform has appointed Eric Peter and Sergie Letser to drive the company’s business development in the US. The expansion to Nanoform’s commercial team will give the company a strengthened presence in the US market and enable a continued rate of rapid global growth, it states. Eric Peter Eric Peter will utilize his business development and […]
In a new job - September 4, 2020
Capitainer appoints new Chief operating Officer
Swedish medtech start-up Capitainer has announced the appointment of Tom Sölch as Chief Operating Officer. Sölch brings experience in medtech sales and operations, most recently with global laboratory supplier VWR. He joins Capitainer as the company enters a period of expansion following the signing of key distribution agreements in the US and Europe for its […]
In a new job - September 2, 2020
A+ Science appoints new CEO
The Board of Directors at A+ Science has appointed Håkan Fröderberg as the new CEO. Håkan Fröderberg has extensive experience from leading positions in several companies within the life science industry. The board is confident that Håkan with his background and experience is the right person to lead and contribute in developing the company, its […]
In a new job - September 1, 2020
Sobi appoints new Head of R&D
Swedish Orphan Biovitrum has announced that Ravi Rao has been appointed Head of Research & Development (R&D) as Milan Zdravkovic will pursue other opportunities outside of the company. Ravi joins from Aeglea Biotherapeutics where he has been the Chief Medical Officer. His previous experience includes roles at GSK where he was Vice President, Global Medical […]
In a new job - August 28, 2020
He is the new Chief Executive Officer of Immunicum
Immunicum has announced that Sven Rohmann has been appointed Chief Executive Officer (CEO) effective immediately. Bringing 30 years of industry experience from biotechnology and pharmaceutical companies as well as life science investment and company sale and acquisition experience, Rohmann will be leading Immunicum as it continues to develop ilixadencel, the company’s cell-based, off-the-shelf immune primer, […]
In a new job - August 25, 2020
She is the new Head of FIMM Metabolomics Unit
Anni Nieminen-Viheriäranta started as the new Head of Metabolomics Unit of the FIMM Technology Centre in May. Her background is in cancer cell biology and metabolic reprogramming. She finished her PhD on cancer and apoptosis in the Faculty of Medicine, University of Helsinki, in 2014. After that, she has worked as an Academy of Finland […]
